| abstract |
Use of a compound represented by formula I, or a pharmaceutically acceptable salt, prodrug, isotope variant or solvate thereof in preparation of a drug: formula I. The drug is used for preventing, alleviating, and/or treating skin diseases or conditions related to anti-tumor agents in a subject. Also disclosed is a method for treating skin diseases or conditions related to anti-tumor agents by using the compound. |